Organization
ICM
2 clinical trials
1 abstract
Clinical trial
A Single Dose Escalation Study of Intra-Articular ICM-203 in Subjects With Kellgren-Lawrence Grade 2 or Grade 3 Osteoarthritis of the KneeStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching PlaceboStatus: , Estimated PCD: 2028-12-01
Abstract
EO2401 (E) peptide immunotherapy + nivolumab (N) +/- bevacizumab (B) in recurrent glioblastoma (GB): EOGBM1-18/ROSALIE.Org: Universitätsklinikum Heidelberg, German Cancer Research Center, Sorbonne Université, AP-HP at Saint-Louis Hospital, ICM,